In light of Eli Lilly's impressive financial performance, strategic expansion, and strong analyst endorsements, the company seems poised for continued growth. Even with its stock trading near all-time ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

The tracker, currently available via a pilot scheme, could save pharmacists hours by reducing patient queries.

At the beginning of the month, the Elon Musk-run company will release its Q3 delivery report. While Tesla’s deliveries fell YoY in the first half of the year, optimism is building ahead of the Q3 ...